Correction to: Clinical Drug Investigation (2023) 43:197–203 https://doi.org/10.1007/s40261-023-01248-9

The article A Cross‑Sectional Study of Tampering in Xtampza ER, an Abuse‑Deterrent Formulation of an Extended‑Release Opioid, in a Treatment Center Population, written by Jennifer Jewell, Joshua Black, Matthew Ellis, Heather Olsen, Janetta Iwanicki and Richard Dart, was originally published Online First without Open Access. After publication in volume 43, issue 3, page 197–203 authors decided that the article be Open Choice to make the article an open access publication. Therefore, the copyright of the article has been changed to © The Author(s) 2023 and the article is forthwith distributed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.

The original article has been corrected.